Richard L. Friedman is a Team Leader of Guidance & Policy in the Division of Manufacturing & Product Quality at FDA’s Center for Drug Evaluation and Research. He began his FDA* career in 1990, and was previously a New Jersey District Office Drug Specialist. As an investigator, he conducted inspections of domestic and foreign drug manufacturers. In his current position, he is responsible for facilitating GMP policy development. He specializes in parenteral drug product issues, including aseptic processing and isolator technology, and chairs CDER's Aseptic Processing Guideline Revision Workgroup. Prior to joining FDA, Mr. Friedman worked in the Industrial Toxicology Research department of an innovator pharmaceutical company. Mr. Friedman received his B.S. in Biology with honors from Montclair State University and his M.S. in Microbiology from Georgetown University School of Medicine in May, 2001.
*FDA representatives are participating in their private capacity, and no endorsement by FDA is intended or inferred

Return to Faculty Home